SCHEMBL5628973

SCHEMBL5628973

Oc1ccc(Br)cc1Oc1ccccc1-c1nnn[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.40
ALOX12 P18054 3/20 0.40
KMT2A Q03164 7/20 0.36
MAPT P10636 6/20 0.36
MEN1 O00255 6/20 0.36
HPGD P15428 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 4/20 0.35
KDM4E B2RXH2 2/20 0.35
TP53 P04637 2/20 0.35
MAPK1 P28482 2/20 0.35
GLA P06280 1/20 0.35
GPR35 Q9HC97 2/20 0.34
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
GAA P10253 1/20 0.33
IDO1 P14902 1/20 0.31
PTGES O14684 1/20 0.31
THRA P10827 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5613919 0.85 IDO1 (0.36) ALOX15ALOX12KMT2AMAPTMEN1
SCHEMBL5606986 0.78 PBRM1 (0.50) KMT2AMEN1KDM4EGPR35GAA
SCHEMBL5614136 0.78 CA3 (0.34) ALOX15ALOX12KMT2AMAPTMEN1
SCHEMBL5614004 0.77 TTR (0.47) KMT2AMAPTMEN1HPGDSMN1; SMN2
SCHEMBL5607912 0.77 KMT2A (0.38) ALOX15ALOX12KMT2AMAPTMEN1
SCHEMBL347489 0.72 ALOX15 (0.66) ALOX15ALOX12KMT2AMAPTMEN1
SCHEMBL30688242 0.72 ALOX15 (0.66) ALOX15ALOX12KMT2AMAPTMEN1
SCHEMBL30554760 0.70 IDO1 (0.52) ALOX15ALOX12KMT2AMAPTMEN1
SCHEMBL1773419 0.70 IDO1 (0.52) ALOX15ALOX12KMT2AMAPTMEN1
SCHEMBL30554759 0.70 IDO1 (0.52) ALOX15ALOX12KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838300-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS Emergent Product Development Gaithersburg Inc. (US) 2007-10-03 EP claimed
US-20060211697-A1 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. 2006-09-21 US claimed
WO-2006071471-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) 2006-07-06 WO claimed
EP-1838300-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS Emergent Product Development Gaithersburg Inc. (US) 2007-10-03 EP disclosed
US-20060211697-A1 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. 2006-09-21 US disclosed
WO-2006071471-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) 2006-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211697-A1 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents TYR, NFE2L2, CYP1A1 ALOX15 2629/4885ALOX12 1678/4885KMT2A 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.